Ignite Creation Date:
2024-07-17 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06473961
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-06-18
Brief Title:
A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of NSCLC
Sponsor:
Shanghai Juncell Therapeutics
Organization:
Shanghai Juncell Therapeutics
Organization Data
Organization:
Shanghai Juncell Therapeutics
Class:
INDUSTRY
Study ID:
GC101 TIL-NSCLC-Ⅰb
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Juncell Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None